Showing 1 to 10 of 16 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T)  Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Lambert Busque Michel-Olivier Gratton 514-252-3400 poste 2397 |
|
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec
Registre NMP Recruiting
|
CIUSSS DU NORD-DE-L'ILE-DE-MONTREAL
HOPITAL DU SACRE-COEUR-DE-MONTREAL
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Inès Chamakhi Caroline Chagnon 514-338-2222 poste 2816 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms Registry in the Province of Quebec (MPN Registry)
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE LAVAL
HOPITAL DE LA CITE-DE-LA-SANTE
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Danielle Talbot Solange Tremblay 450-668-1010 poste 23603 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE LA MONTEREGIE-CENTRE
HOPITAL CHARLES-LE MOYNE
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Pierre Desjardins Caroline Millette 450-466-5000 poste 3276 |
|
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
INCA 33989-101 NCT05936359 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Natasha Szuber Julie Trinh Lu 514-252-3400 poste 3336 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T) Recruiting
|
CISSS DE CHAUDIERE-APPALACHES
HOTEL-DIEU DE LEVIS
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Danièle Marceau Pierre Bédard 418-835-7121 |
|
A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination With Ruxolitinib Versus Best Available Therapy in Subjects With Relapsed/Refractory Myelofibrosis
TRANSFORM-2 NCT04468984 Recruiting
|
CISSS DE CHAUDIERE-APPALACHES
HOTEL-DIEU DE LEVIS
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Danièle Marceau Pierre Bédard 418-835-7121 |
|
A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients With Phlebotomy Dependent Polycythemia Vera (PD-PV)
ISIS 702843-CS4 NCT05143957 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Jonathan How Judit Kokai 438-888-1582 |
|
A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Navitoclax in Combination With Ruxolitinib Versus Best Available Therapy in Subjects With Relapsed/Refractory Myelofibrosis
TRANSFORM-2 NCT04468984 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Jonathan How Judit Kokai 438-888-1582 |
|
A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Registre des NMP (CINC424BCA04T) Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
MPN: Vaquez, Essential Thrombocytemia, Myeloid Metaplasia |
Dr. Marc Lalancette Patricia Chabot 418-525-4444 poste 15769 |
Groupe d'étude en oncologie du Québec